FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214658037> ?p ?o ?g. }

• W4214658037 endingPage "1177" @default.
• W4214658037 startingPage "1177" @default.
• W4214658037 abstract "Doxorubicin (DOX) is one of the most effective cytotoxic agents against malignant diseases. However, the clinical application of DOX is limited, due to dose-related toxicity. The development of DOX nanoformulations that significantly reduce its toxicity and affect the metabolic pathway of the drug requires improved methods for the quantitative determination of DOX metabolites with high specificity and sensitivity. This study aimed to develop a high-throughput method based on high-performance liquid chromatography with fluorescence detection (HPLC-FD) for the quantification of DOX and its metabolites in the urine of laboratory animals after treatment with different DOX nanoformulations. The developed method was validated by examining its specificity and selectivity, linearity, accuracy, precision, limit of detection, and limit of quantification. The DOX and its metabolites, doxorubicinol (DOXol) and doxorubicinone (DOXon), were successfully separated and quantified using idarubicin (IDA) as an internal standard (IS). The linearity was obtained over a concentration range of 0.05-1.6 μg/mL. The lowest limit of detection and limit of quantitation were obtained for DOXon at 5.0 ng/mL and 15.0 ng/mL, respectively. For each level of quality control (QC) samples, the inter- and intra-assay precision was less than 5%. The accuracy was in the range of 95.08-104.69%, indicating acceptable accuracy and precision of the developed method. The method was applied to the quantitative determination of DOX and its metabolites in the urine of rats treated by novel nanoformulated poly(lactic-co-glycolic acid) (DOX-PLGA), and compared with a commercially available DOX solution for injection (DOX-IN) and liposomal-DOX (DOX-MY)." @default.
• W4214658037 created "2022-03-02" @default.
• W4214658037 creator A5001514761 @default.
• W4214658037 creator A5010261267 @default.
• W4214658037 creator A5019082497 @default.
• W4214658037 creator A5042364842 @default.
• W4214658037 creator A5053415491 @default.
• W4214658037 creator A5074064252 @default.
• W4214658037 creator A5080469484 @default.
• W4214658037 creator A5081544780 @default.
• W4214658037 date "2022-02-09" @default.
• W4214658037 modified "2023-10-18" @default.
• W4214658037 title "High-Throughput Method for the Simultaneous Determination of Doxorubicin Metabolites in Rat Urine after Treatment with Different Drug Nanoformulations" @default.
• W4214658037 cites W125325141 @default.
• W4214658037 cites W1971711278 @default.
• W4214658037 cites W1972536070 @default.
• W4214658037 cites W1976704016 @default.
• W4214658037 cites W1985892485 @default.
• W4214658037 cites W1995650484 @default.
• W4214658037 cites W1998203899 @default.
• W4214658037 cites W2004805630 @default.
• W4214658037 cites W2008388668 @default.
• W4214658037 cites W2043485992 @default.
• W4214658037 cites W2051732812 @default.
• W4214658037 cites W2061510929 @default.
• W4214658037 cites W2067821900 @default.
• W4214658037 cites W2072069308 @default.
• W4214658037 cites W2074544441 @default.
• W4214658037 cites W2091285513 @default.
• W4214658037 cites W2092548211 @default.
• W4214658037 cites W2095412415 @default.
• W4214658037 cites W2102897174 @default.
• W4214658037 cites W2106473427 @default.
• W4214658037 cites W2127173211 @default.
• W4214658037 cites W2160551609 @default.
• W4214658037 cites W2170119150 @default.
• W4214658037 cites W2199344695 @default.
• W4214658037 cites W2395389399 @default.
• W4214658037 cites W2528235455 @default.
• W4214658037 cites W2599276599 @default.
• W4214658037 cites W2735767394 @default.
• W4214658037 cites W2754374643 @default.
• W4214658037 cites W2770439161 @default.
• W4214658037 cites W2890176306 @default.
• W4214658037 cites W2898712541 @default.
• W4214658037 cites W2901097745 @default.
• W4214658037 cites W2914087400 @default.
• W4214658037 cites W3025080581 @default.
• W4214658037 cites W3049020037 @default.
• W4214658037 cites W3131976636 @default.
• W4214658037 doi "https://doi.org/10.3390/molecules27041177" @default.
• W4214658037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35208967" @default.
• W4214658037 hasPublicationYear "2022" @default.
• W4214658037 type Work @default.
• W4214658037 citedByCount "2" @default.
• W4214658037 countsByYear W42146580372022 @default.
• W4214658037 countsByYear W42146580372023 @default.
• W4214658037 crossrefType "journal-article" @default.
• W4214658037 hasAuthorship W4214658037A5001514761 @default.
• W4214658037 hasAuthorship W4214658037A5010261267 @default.
• W4214658037 hasAuthorship W4214658037A5019082497 @default.
• W4214658037 hasAuthorship W4214658037A5042364842 @default.
• W4214658037 hasAuthorship W4214658037A5053415491 @default.
• W4214658037 hasAuthorship W4214658037A5074064252 @default.
• W4214658037 hasAuthorship W4214658037A5080469484 @default.
• W4214658037 hasAuthorship W4214658037A5081544780 @default.
• W4214658037 hasBestOaLocation W42146580371 @default.
• W4214658037 hasConcept C119128265 @default.
• W4214658037 hasConcept C141071460 @default.
• W4214658037 hasConcept C179998833 @default.
• W4214658037 hasConcept C185592680 @default.
• W4214658037 hasConcept C2776694085 @default.
• W4214658037 hasConcept C2777477808 @default.
• W4214658037 hasConcept C2780026642 @default.
• W4214658037 hasConcept C2781303535 @default.
• W4214658037 hasConcept C43617362 @default.
• W4214658037 hasConcept C55493867 @default.
• W4214658037 hasConcept C71924100 @default.
• W4214658037 hasConcept C98274493 @default.
• W4214658037 hasConceptScore W4214658037C119128265 @default.
• W4214658037 hasConceptScore W4214658037C141071460 @default.
• W4214658037 hasConceptScore W4214658037C179998833 @default.
• W4214658037 hasConceptScore W4214658037C185592680 @default.
• W4214658037 hasConceptScore W4214658037C2776694085 @default.
• W4214658037 hasConceptScore W4214658037C2777477808 @default.
• W4214658037 hasConceptScore W4214658037C2780026642 @default.
• W4214658037 hasConceptScore W4214658037C2781303535 @default.
• W4214658037 hasConceptScore W4214658037C43617362 @default.
• W4214658037 hasConceptScore W4214658037C55493867 @default.
• W4214658037 hasConceptScore W4214658037C71924100 @default.
• W4214658037 hasConceptScore W4214658037C98274493 @default.
• W4214658037 hasIssue "4" @default.
• W4214658037 hasLocation W42146580371 @default.
• W4214658037 hasLocation W42146580372 @default.
• W4214658037 hasLocation W42146580373 @default.
• W4214658037 hasLocation W42146580374 @default.
• W4214658037 hasLocation W42146580375 @default.
• W4214658037 hasOpenAccess W4214658037 @default.

• next